๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes

โœ Scribed by C. ROSAK; E. STANDL; T. REBLIN; H. STAMMER; D. K. SEIDEL


Book ID
111308048
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
753 KB
Volume
60
Category
Article
ISSN
1368-5031

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES